InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Loose Christopher R., Directeur Scientifique. Officer active across 1 company, notably Frequency Therapeutics, Inc.. Cumulatively, 4 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €10k. Activity tracked since 16 February 2022. The latest transaction was disclosed on 18 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
974 shares@ US$3.87333.3% of flowCommon StockSEC:0001127602-22-006339:0
851 shares@ US$4.42933.3% of flowCommon StockSEC:0001127602-22-005752:0
851 shares@ US$4.429100.0% of flowCommon StockSEC:0001127602-22-005752
15,000 sharesCommon StockSEC:0001127602-22-005331:0
4 of 4 declarations
About Loose Christopher R.
Christopher R. Loose is the Chief Scientific Officer of Frequency Therapeutics, Inc. In this role, he is responsible for scientific leadership and innovation within the company. Christopher plays a key role in developing new therapies and technologies, thereby contributing to advancements in science and health. His expertise is essential in positioning Frequency Therapeutics as a leader in the biotechnology field.
